Home
Drugs
Targets
Pathways
Ontologies
Cyp450s
Adv.search
Help/FAQ

Drug-Target Interaction

Drug

show drug details
PubChem ID:2230
Structure:
Synonyms:
1,2,5,6-Tetrahydro-1-methyl-3-pyridinecarboxylic acid methyl ester
1,2,5,6-Tetrahydro-1-methyl-3-pyridinecarboxylic acid, methyl ester
1,2,5,6-Tetrahydro-1-methylnicotinic acid, methyl ester
1-Methyl-delta(sup 3,4)tetrahydro-3-pyridinecarboxylate
3-Pyridinecarboxylic acid, 1,2,5,6-tetrahydro-1-methyl-, methyl ester
5-22-01-00322 (Beilstein Handbook Reference)
63-75-2
AC1L1D7O
AC1Q43OG
AC1Q5YXA
ACon1_002372
AIDS-002686
AIDS002686
AKOS000520752
AR-1H7528
Arecaidine methyl ester
Arecaline
Arecholin
Arecholine
Arecolin
Arecoline
Arecoline base
Arecoline hydrobromide
Arekolin
BPBio1_000358
BRD-K88646909-004-05-5
BRD-K88646909-004-06-3
BRN 0123045
BSPBio_000324
BSPBio_002974
C10129
C8H13NO2
CAS-300-08-3
CCG-204145
CCRIS 7688
CHEBI:101022
CHEMBL7303
D001115
DB04365
DivK1c_000810
EINECS 200-565-5
IDI1_000810
KBio1_000810
KBio2_000435
KBio2_003003
KBio2_005571
KBio3_002194
KBioGR_001299
KBioSS_000435
L000795
Lopac-A-6134
Lopac0_000049
LS-96624
MEGxp0_001891
Methyl 1,2,5,6-tetrahydro-1-methylnicotinate
methyl 1-methyl-1,2,5,6-tetrahydropyridine-3-carboxylate
methyl 1-methyl-3,6-dihydro-2H-pyridine-5-carboxylate
methyl 1-methyl-5,6-dihydro-2H-pyridine-3-carboxylate
Methyl N-methyl-1,2,5,6-tetrahydronicotinate
Methyl N-methyltetrahydronicotinate
Methylarecaiden
Methylarecaidin
MolPort-006-110-167
N-Methyl-.delta.-tetrahydronicotinic acid methyl ester
N-Methyltetrahydronicotinic acid, methyl ester
N-Methyltetrahydropyridine-.beta.-carboxylic acid methyl ester
N-Methyltetrahydropyridine-beta-carboxylic acid methyl ester
NCGC00015075-01
NCGC00015075-02
NCGC00015075-03
NCGC00015075-04
NCGC00015075-05
NCGC00015075-06
NCGC00015075-07
NCGC00162053-01
NCGC00162053-02
NCGC00162053-03
Nicotinic acid, 1,2,5,6-tetrahydro-1-methyl-, methyl ester
NINDS_000810
NSC 56321
NSC56321
Piperidine alkaloid
Prestwick0_000402
Prestwick1_000402
Prestwick2_000402
Prestwick3_000402
SDCCGMLS-0066647.P001
SPBio_000201
SPBio_002263
Spectrum2_000051
Spectrum3_001387
Spectrum4_000810
Spectrum5_001316
Spectrum_000055
ST095172
UNII-4ALN5933BH
WLN: T6N CUTJ A1 CVO1

Target

show target details
Uniprot ID:CP1A1_HUMAN
Synonyms:
CYPIA1
Cytochrome P450 1A1
P450 form 6
P450-C
P450-P1
EC-Numbers:1.14.14.1
Organism:Homo sapiens
Human
PDB IDs:-

Binding Affinities:

Ki: Kd:Ic 50:Ec50/Ic50:
----

References:

17707585
Differential effect of arecoline on the endogenous dioxin-responsive cytochrome P450 1A1 and on a stably transfected dioxin-responsive element-driven reporter in human hepatoma cells.. How-Ran Chao; Ya-Fen Wang; Hung-Ta Chen; Ying-Chin Ko; Eddy Essen Chang; Yuh-Jeen Huang; Feng-Yuan Tsai; Cheng-Hsien Tsai; Chia-Hsin Wu; Tsui-Chun Tsou (2007) Journal of hazardous materials display abstract
Dioxin-responsive element-mediated chemical activated luciferase expression (DRE-CALUX) is one of alternative bioassays for the determination of dioxin levels. We have previously established a DRE-CALUX cell line, Huh7-DRE-Luc, by using stable transfection of Huh-7 cells with a reporter plasmid (4xDRE-TATA-Luc) carrying a DRE-driven firefly luciferase gene. It was also shown that arecoline, a major areca nut alkaloid, inhibited the 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced cytochrome P450 1A1 (CYP1A1) activation in Huh-7 cells. The TCDD-activated aryl hydrocarbon receptor (AhR) induces the DRE-CALUX activation and CYP1A1 gene expression via binding to DRE in promoter regions of these dioxin-responsive genes. In the present study, the effect of arecoline on the TCDD-induced activation of DRE-CALUX and CYP1A1 enzyme in Huh7-DRE-Luc and Huh-7 cells, respectively, was examined. It was found that arecoline inhibited TCDD-induced CYP1A1 activation and however enhanced TCDD-induced DRE-CALUX activation. This finding indicates the differential effect of arecoline on the endogenous dioxin-responsive CYP1A1 and on a stably transfected DRE-driven reporter in human hepatoma cells. The present study suggests that induction of DRE-CALUX alone does not necessarily parallel with endogenous CYP1A1 gene expression, and that the reporter assay may detect interactions that are not functional in endogenous gene.